scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBRC.2009.09.015 |
P698 | PubMed publication ID | 19737535 |
P50 | author | Kazunori Takenouchi | Q42930677 |
Salunya Tancharoen | Q57273541 | ||
P2093 | author name string | Takashi Ito | |
Kenji Nakayama | |||
Xiaojie Meng | |||
Yoshihiro Yoshida | |||
Ikuro Maruyama | |||
Ko-Ichi Kawahara | |||
Fumiyo Matsuda | |||
Naoki Miura | |||
Binita Shrestha | |||
Teruto Hashiguchi | |||
Kiyoshi Kikuchi | |||
Hisayo Sameshima | |||
Yuko Nawa | |||
Minoru Shigemori | |||
Masahiro Iwata | |||
Noboru Arimura | |||
Terukazu Kuramoto | |||
Yutaka Tajima | |||
Hisaaki Uchikado | |||
Kentaro Mera | |||
Yoko Morimoto | |||
Ryuichi Maenosono | |||
Yoko Oyama | |||
Kamal Krishna Biswas | |||
Shinichiro Arimura | |||
Yoshiko Ohno | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | edaravone | Q335099 |
P304 | page(s) | 1121-1125 | |
P577 | publication date | 2009-09-06 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4 | |
P478 | volume | 390 |
Q33938450 | A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? |
Q39427640 | A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model |
Q26863595 | Antioxidants: The new frontier for translational research in cerebroprotection |
Q34898573 | Aquaporins in cerebrovascular disease: a target for treatment of brain edema? |
Q33912746 | Aquaporins in spinal cord injury: the janus face of aquaporin 4 |
Q37869174 | Astrocytes: targets for neuroprotection in stroke. |
Q36097037 | Clinical neuroprotective drugs for treatment and prevention of stroke |
Q38243696 | Clinical trials in acute ischemic stroke |
Q28582197 | CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes |
Q43161921 | Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy |
Q42408578 | Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke |
Q47802895 | Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway |
Q28550314 | Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse |
Q47137226 | Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis. |
Q51894025 | Perspectives on neonatal hypoxia/ischemia-induced edema formation. |
Q37601595 | Potential application of in vivo imaging of impaired lymphatic duct to evaluate the severity of pressure ulcer in mouse model |
Q43079903 | Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction. |
Q35171343 | Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats |
Q26738736 | Progress in AQP Research and New Developments in Therapeutic Approaches to Ischemic and Hemorrhagic Stroke |
Q38335788 | Regulation and Function of AQP4 in the Central Nervous System |
Q47720350 | The Oxidative Stress-Induced Increase in the Membrane Expression of the Water-Permeable Channel Aquaporin-4 in Astrocytes Is Regulated by Caveolin-1 Phosphorylation |
Q38437151 | The central role of aquaporins in the pathophysiology of ischemic stroke. |
Q27015129 | The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease |
Q30584804 | Using the olfactory system as an in vivo model to study traumatic brain injury and repair |
Q39711306 | Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation |
Q38591758 | Vagus Nerve Stimulation and Other Neuromodulation Methods for Treatment of Traumatic Brain Injury |
Search more.